337
Views
0
CrossRef citations to date
0
Altmetric
Letter to the Editor

KRAS mutational test for metastatic colorectal cancer patients: not just a technical problem

, , , &
Pages 327-328 | Published online: 09 Jan 2014

References

  • Molinari F, Frattini M. KRAS mutational test for metastatic colorectal cancer patients: not just a technical problem. Expert Rev. Mol. Diagn.12(2), 123–126 (2012).
  • Hamfjord J, Stangeland AM, Skrede ML, Tveit KM, Ikdahl T, Kure EH. Wobble enhanced ARMS (WE-ARMS) method for detecting KRAS and BRAF mutations in patients with advanced colorectal cancer. Diagn. Mol. Pathol.20(3), 158–165 (2011).
  • Tveit KM, Guren T, Glimelius B et al. Phase III trial of cetuximab with continuous or intermittent fluorouracil, leucovorin and oxaliplatin (Nordic FLOX) versus FLOX alone in first-line treatment of metastatic colorectal cancer: the NORDIC-VII study. J. Clin. Oncol. (2012) (In Press).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.